|
1) Haberfeld W, Spieler F. Zur diffusen Hirn-Rueckenmarksclerose im Kindesalter. Dich Nervenh. 1910; 40: 436
|
|
|
|
|
2) Moser HW, Smith KD, Watkins PA, et al. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D. editiors. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 2001. p.3257-301
|
|
|
|
|
|
3) Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993; 361: 726-30
|
|
|
|
|
4) Raymond GV, Seidman R, Monteith TS, et al. Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci. 2010; 290: 70-4
|
|
|
|
|
5) Fourcade S, Ruiz M, Camps C, et al. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab. 2009; 296: E211-21
|
|
|
|
|
|
6) Suzuki Y, Shimozawa N, Yajima S, et al. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem Pharmacol. 1991; 41: 453-6
|
|
|
|
|
|
7) Igarashi M, Schaumburg HH, Powers J, et al. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976; 26: 851-60
|
|
|
|
|
|
8) Tsuji S, Ohno T, Miyatake T, et al. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD) J Biochem. 1984; 96: 1241-7
|
|
|
|
|
9) Rizzo WB, Leshner RT, Odone A, et al. Dietary erucic acid therapy for X-linked adrenoleuko-dystrophy. Neurology. 1989; 39: 1415-22
|
|
|
|
|
|
10) Moser HW, Raymond GV, Lu SE, et al. Follow-up of 89 asymptomatic patients with adrenoleuko-dystrophy treated with Lorenzoʼs oil. Arch Neurol. 2005; 62: 1073-80
|
|
|
|
|
|
11) Aubourg P, Blanche S, Jambaqué I, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990; 322: 1860-6
|
|
|
|
|
|
12) Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleuko-dystrophy. Science. 2009; 326: 818-23
|
|
|
|
|
|
13) Hitomi T, Mezaki T, Tomimoto H, et al. Long-term effect of bone marrow transplantation in adult-onset adrenoleukodystrophy. Eur J Neurol. 2005; 12: 807-10
|
|
|
|
|
|
14) Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004; 104: 881-8
|
|
|
|
|
|
15) 加藤俊一, 矢部普正. 副腎白質ジストロフィー(ALD)における造血幹細胞移植に関する研究. 厚生労働省難治性疾患克服研究事業平成19年度報告書. 2008; p.19-23
|
|
|
|
|
|
16) Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003; 61: 369-74
|
|
|
|
|
|
17) Raymond GV, Jones RO, Moser AB. Newborn screening for adrenoleukodystrophy: implications for therapy. Mol Diagn Ther. 2007; 11: 381-4
|
|
|
|
|
|
18) 加藤剛二, 加藤俊一. 副腎白質ジストロフィー症に対する造血幹細胞移植. 厚生労働省難治性疾患克服研究事業平成21年度報告書. 2010. p.86-8
|
|
|
|
|
|
19) 加藤俊一, 矢部普正, 矢部みはる, 他. 副腎白質ジストロフィー造血幹細胞移植後のキメリズムの推移に関する研究. 厚生労働省難治性疾患克服研究事業平成21年度報告書. 2010. p.89-92
|
|
|
|
|
|
20) Sadeghi-Nejad A, Senior B. Adrenomyelo-neuropathy presenting as Addisonʼs disease in childhood. N Engl J Med. 1990; 322: 13-6
|
|
|
|
|